Dr. Diana Röttger

Investing @LifeArc Ventures

📍 United Kingdom🔄 Updated September 2026💼 6 investments📅 5 years investing🗓 Last invested Jan 2025
VC🌍 United Kingdom
6
Total investments
2
Early stage
2
Mid stage
2
Late stage
5y
Years active

Portfolio

6 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Board Member
Jan 2025
Mindpeaks mission is to enable personalised cancer treatment through AI tissue diagnostics Our partners are leading pathology and university labs. Our team consists of world-class industry experts in machine learning and company building. Mindpeaks Impact The demand for medical image analysis is growing rapidly but the number of cancer experts remains the same - this results in growing workloads per specialist. We help cancer experts meet this challenge. We build automation tools for visual diagnosis using state-of-the-art artificial intelligence and deep learning. Our tools assist cancer experts in providing reliable and reproducible diagnoses. This frees specialists from tedious, repetitive tasks such as quantification of cells or biomarkers and allows them to focus on tasks where their human expertise is indispensable. If you want to get in touch with us send us an E-Mail via info@mindpeak.ai.
Board Observer
Jan 2024
Detecting brain diseases radically early using the way you speak.
Board Observer
Feb 2023
At Quibim, we design pioneering tools that unlock imaging data to improve patient outcomes. Our main purpose is the application of AI techniques to medical images from MRI, CT, PET to unlock new data which can be transformed into actionable predictions for life sciences and providers.
Board Member
Apr 2022
CardiaTec is applying artificial intelligence on large-scale human multi-omics data to develop the next generation of cardiovascular disease drug targets.
Board Member
Feb 2022
Robeauté is pioneering a new class of therapeutic microrobots—engineered to diagnose, treat and monitor the brain with unprecedented flexibility and precision. We are a pluridisciplinary and multicultural team of passionate, supportive and creative people, at the crossroads of microrobotics, engineering and medicine. We are team players, with both classical and atypical backgrounds, so unconventional thinking is welcome and good communication skills are a must. Our team is growing and we are constantly on the lookout for incredible talent and grit. We are based in Paris, France. Check out our open roles: https://apply.workable.com/robeaute/ Follow us here as we tell you more of what we do.
Angel Investor at Alma
Oct 2021
Alma Angels is a diverse and active community with a bold mission: Generate $1 trillion in women-led wealth by 2050. Since 2020, we have brought together and trained over 500 angel investors who have invested into 200+ women (co)founders building tech or IP-rich ventures with global ambitions. These companies have gone on to raise more than £300m to date. Alma Angels is committed to training 10,000 angels and backing 10,000 women founders by 2035.
Experience · 9 entries
All (9)
Investments (6)
Board (5)
2025
Investment Principal
Jun 2025
LifeArc Ventures invests in early-stage science-led companies that can benefit from our advice, scientific insight and venture funding. We’re committed to encouraging and financing innovative, early-stage life science companies to help them positively impact the lives of patients. As part of the medical research charity LifeArc, we offer a unique combination of scientific, commercial and financial support. We have access to leading scientists with the skills and expertise to understand translational science at a deep level, enabling us to make educated and informed decisions around our investments, and to help our portfolio companies achieve meaningful progress
Board Member
Jan 2025
Mindpeaks mission is to enable personalised cancer treatment through AI tissue diagnostics Our partners are leading pathology and university labs. Our team consists of world-class industry experts in machine learning and company building. Mindpeaks Impact The demand for medical image analysis is growing rapidly but the number of cancer experts remains the same - this results in growing workloads per specialist. We help cancer experts meet this challenge. We build automation tools for visual diagnosis using state-of-the-art artificial intelligence and deep learning. Our tools assist cancer experts in providing reliable and reproducible diagnoses. This frees specialists from tedious, repetitive tasks such as quantification of cells or biomarkers and allows them to focus on tasks where their human expertise is indispensable. If you want to get in touch with us send us an E-Mail via info@mindpeak.ai.
2024
Board Observer
Jan 2024
Detecting brain diseases radically early using the way you speak.
2023
Board Observer
Feb 2023
At Quibim, we design pioneering tools that unlock imaging data to improve patient outcomes. Our main purpose is the application of AI techniques to medical images from MRI, CT, PET to unlock new data which can be transformed into actionable predictions for life sciences and providers.
2022
Board Member
Apr 2022
CardiaTec is applying artificial intelligence on large-scale human multi-omics data to develop the next generation of cardiovascular disease drug targets.
Show all 9 entries ↓
Investment activity
2021–2025 · 6 investments
2021120222202312024120251
Recent (last 2 years)Earlier